Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 881202

MicroRNAs as cancer therapeutics: A step closer to clinical application

Catela Ivković, Tina; Voss, Gjendine; Cornella, Helena; Ceder, Yvonne
microRNAs as cancer therapeutics: A step closer to clinical application // Cancer letters, 407 (2017), 113-122 doi:10.1016/j.canlet.2017.04.007 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 881202 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
MicroRNAs as cancer therapeutics: A step closer to clinical application

Autori
Catela Ivković, Tina ; Voss, Gjendine ; Cornella, Helena ; Ceder, Yvonne

Izvornik
Cancer letters (0304-3835) 407 (2017); 113-122

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Metastases ; Therapy resistance ; Drug delivery ; miR-34a ; miR-15/16 ; miR-155

Sažetak
During the last decades, basic and translational research has enabled great improvements in the clinical management of cancer. However, scarcity of complete remission and many drug-induced toxicities are still a major problem in the clinics. Recently, microRNAs (miRNAs) have emerged as promising therapeutic targets due to their involvement in cancer development and progression. Their extraordinary regulatory potential, which enables regulation of entire signalling networks within the cells, makes them an interesting tool for the development of cancer therapeutics. In this review we will focus on miRNAs with experimentally proven therapeutic potential, and discuss recent advances in the technical development and clinical evaluation of miRNA-based therapeutic agents.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA

Projekti:
098-0982464-2508 - Molekularna genetika i farmakogenetika gastrointestinalnih tumora (Kapitanović, Sanja, MZOS ) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Tina Catela Ivković (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com doi.org

Citiraj ovu publikaciju:

Catela Ivković, Tina; Voss, Gjendine; Cornella, Helena; Ceder, Yvonne
microRNAs as cancer therapeutics: A step closer to clinical application // Cancer letters, 407 (2017), 113-122 doi:10.1016/j.canlet.2017.04.007 (međunarodna recenzija, članak, znanstveni)
Catela Ivković, T., Voss, G., Cornella, H. & Ceder, Y. (2017) microRNAs as cancer therapeutics: A step closer to clinical application. Cancer letters, 407, 113-122 doi:10.1016/j.canlet.2017.04.007.
@article{article, author = {Catela Ivkovi\'{c}, Tina and Voss, Gjendine and Cornella, Helena and Ceder, Yvonne}, year = {2017}, pages = {113-122}, DOI = {10.1016/j.canlet.2017.04.007}, keywords = {Metastases, Therapy resistance, Drug delivery, miR-34a, miR-15/16, miR-155}, journal = {Cancer letters}, doi = {10.1016/j.canlet.2017.04.007}, volume = {407}, issn = {0304-3835}, title = {microRNAs as cancer therapeutics: A step closer to clinical application}, keyword = {Metastases, Therapy resistance, Drug delivery, miR-34a, miR-15/16, miR-155} }
@article{article, author = {Catela Ivkovi\'{c}, Tina and Voss, Gjendine and Cornella, Helena and Ceder, Yvonne}, year = {2017}, pages = {113-122}, DOI = {10.1016/j.canlet.2017.04.007}, keywords = {Metastases, Therapy resistance, Drug delivery, miR-34a, miR-15/16, miR-155}, journal = {Cancer letters}, doi = {10.1016/j.canlet.2017.04.007}, volume = {407}, issn = {0304-3835}, title = {microRNAs as cancer therapeutics: A step closer to clinical application}, keyword = {Metastases, Therapy resistance, Drug delivery, miR-34a, miR-15/16, miR-155} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.